Teva Homepage Print this page Site Map
Teva investor relationsAbout TevaTeva Worldwide

Investor Relations

Webcasts  
Email Alerts
Get Email Alerts


Stock Info


Quick Links

Historical Financial Data -
Income Statement and Balance
Sheet (2006 to Q1 2009 )


FAQs for Former
Barr Shareholders


Notice of Annual Meeting of
Shareholders 2009
Proxy Statement

 
More...


Reconciliation table:
2006-2008


Notices Relating to Convertible Debentures
Wednesday, June 10, 2009
Replay : Presentation at the Goldman Sach 30th Annual Global Healthcare Conference
Wednesday, May 27, 2009
Replay : Presentation at the Sanford C. Bernstein & Co., LLC Strategic Decisions Conference 2009

     More...
 
   
Presentations  
March 18, 2009
Presentation at the Cowen & Co.
29th Annual Healthcare Conference - PDF 1.42 MB

February 18, 2009
Teva Investor and Analyst
Meeting Presentation - PDF 3.66 MB

February 17, 2008
4th Quarter and Full Year 2008
Investor Presentation (Israel) - PDF 2.80 MB

    More...
 
   
News & PR  
Jerusalem, Israel, July 1, 2009
Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets

Jerusalem, Israel and Ewing, New Jersey, June 30, 2009
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin® (Human Growth Hormone)

    More...

 

 

 
   




Back to Top